Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6AbbVie Corporation

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Palivizumab

Brand Name : SYNAGIS

Patent Number : 2197684

Filing Date : 1995-08-09

Strength per Unit : 50 mg

Dosage Form : Powder and Diluent for Injectable Solution

Human Or VET : Human

Route of Administration : Intramuscular Injection

Patent Expiration Date : 2015-08-09

Date Granted : 2000-10-31

Abbvie Company Banner

02

Palivizumab

Brand Name : SYNAGIS

Patent Number : 2197684

Filing Date : 1995-08-09

Strength per Unit : 100 mg

Dosage Form : Powder and Diluent for Injectable Solution

Human Or VET : Human

Route of Administration : Intramuscular Injection

Patent Expiration Date : 2015-08-09

Date Granted : 2000-10-31

Abbvie Company Banner

03

PALIVIZUMAB

Brand Name : SYNAGIS

Patent Number : 2197684

Filing Date : 1995-08-09

Strength per Unit : 50mg / 0.5 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAMUSCULAR

Patent Expiration Date : 2015-08-09

Date Granted : 2000-10-31

Abbvie Company Banner

04

PALIVIZUMAB

Brand Name : SYNAGIS

Patent Number : 2489632

Filing Date : 2003-06-16

Strength per Unit : 50mg / 0.5 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAMUSCULAR

Patent Expiration Date : 2023-06-16

Date Granted : 2015-08-18

Abbvie Company Banner

05

PALIVIZUMAB

Brand Name : SYNAGIS

Patent Number : 2197684

Filing Date : 1995-08-09

Strength per Unit : 100mg / 1 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAMUSCULAR

Patent Expiration Date : 2015-08-09

Date Granted : 2000-10-31

Abbvie Company Banner

06

PALIVIZUMAB

Brand Name : SYNAGIS

Patent Number : 2489632

Filing Date : 2003-06-16

Strength per Unit : 100mg / 1 mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAMUSCULAR

Patent Expiration Date : 2023-06-16

Date Granted : 2015-08-18

Abbvie Company Banner